Literature DB >> 6995687

Escape from the sodium-retaining effects of mineralocorticoids.

F G Knox, J C Burnett, D E Kohan, W S Spielman, J C Strand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6995687     DOI: 10.1038/ki.1980.32

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  11 in total

Review 1.  Intrinsic control of sodium excretion in the distal nephron by inhibitory purinergic regulation of the epithelial Na(+) channel.

Authors:  Glenn M Toney; Volker Vallon; James D Stockand
Journal:  Curr Opin Nephrol Hypertens       Date:  2012-01       Impact factor: 2.894

2.  A urine-concentrating defect in 11β-hydroxysteroid dehydrogenase type 2 null mice.

Authors:  Louise C Evans; Dawn E Livingstone; Christopher J Kenyon; Maurits A Jansen; James W Dear; John J Mullins; Matthew A Bailey
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-23

3.  Purinergic inhibition of ENaC produces aldosterone escape.

Authors:  James D Stockand; Elena Mironova; Vladislav Bugaj; Timo Rieg; Paul A Insel; Volker Vallon; Janos Peti-Peterdi; Oleh Pochynyuk
Journal:  J Am Soc Nephrol       Date:  2010-09-02       Impact factor: 10.121

4.  Blood volume changes and arginine vasotocin (AVT) blood concentration in conscious fresh water and salt water adapted ducks.

Authors:  C Simon-Oppermann; D Gray; E Szczepanska-Sadowska; E Simon
Journal:  Pflugers Arch       Date:  1984-02       Impact factor: 3.657

5.  Atrial natriuretic peptide transcription, secretion, and glomerular receptor activity during mineralocorticoid escape in the rat.

Authors:  B J Ballermann; K D Bloch; J G Seidman; B M Brenner
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

Review 6.  Aldosterone biosynthesis, regulation, and classical mechanism of action.

Authors:  Gordon H Williams
Journal:  Heart Fail Rev       Date:  2005-01       Impact factor: 4.214

7.  Effect of dibutyryl cyclic AMP on plasma renin activity in normal men and patients with primary aldosteronism.

Authors:  N Fukuda; M Soma; A Kubo; M Kunimoto; Y Watanabe; Y Izumi; K Kanmatsuse
Journal:  J Endocrinol Invest       Date:  1997-01       Impact factor: 4.256

8.  Effects of Treating Primary Aldosteronism on Renal Function.

Authors:  Bart J Kramers; Cornelis Kramers; Jacques W M Lenders; Jaap Deinum
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-09-23       Impact factor: 3.738

9.  Aldosterone escape with diuretic or angiotensin-converting enzyme inhibitor/angiotensin II receptor blocker combination therapy in patients with mild to moderate hypertension.

Authors:  Samira Ubaid-Girioli; Sílvia Elaine Ferreira-Melo; Leoní Adriana Souza; Eduardo Arantes Nogueira; Juan Carlos Yugar-Toledo; Antonio Coca; Heitor Moreno
Journal:  J Clin Hypertens (Greenwich)       Date:  2007-10       Impact factor: 3.738

10.  Plasma adrenocorticotropic hormone but not aldosterone is correlated with blood pressure in patients with aldosterone-producing adenomas.

Authors:  Hiroki Kobayashi; Akira Haketa; Ueno Takahiro; Hiromasa Otsuka; Sho Tanaka; Yoshinari Hatanaka; Yukihiro Ikeda; Masanori Abe; Noboru Fukuda; Masayoshi Soma
Journal:  J Clin Hypertens (Greenwich)       Date:  2016-12-05       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.